Drug intelligence / Profile preview

paracetamol + dexamethasone

Development stage
Unknown
Lead developer
Université de Monastir
Modality
Small Molecules
Administration
Intravenous
01

Overview

This combination therapy involves the co-administration of paracetamol (acetaminophen) and dexamethasone for the management of acute renal colic pain. Paracetamol is a non-opioid analgesic and antipyretic that acts primarily by inhibiting prostaglandin synthesis in the central nervous system. Dexamethasone is a potent, long-acting synthetic glucocorticoid with significant anti-inflammatory and immunosuppressive properties. In a clinical trial conducted by the University of Monastir, intravenous dexamethasone (8mg) is being evaluated as an adjuvant to intravenous paracetamol (1000mg) to determine if it provides superior pain relief compared to paracetamol alone or paracetamol combined with nebulized salbutamol. The rationale for using dexamethasone in renal colic is to reduce the inflammatory response and ureteral edema associated with the passage of urinary stones, thereby potentially enhancing the analgesic effect of paracetamol.

Other names
dexamethasone + paracetamolintravenous paracetamol and intravenous dexamethasoneparacetamol and dexamethasone combination
02

Targets

GR (Glucocorticoid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on paracetamol + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call